![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, June 19, 2005 12:38:53 PM
Most of my pessimism originated from the failed BioFrontera Deal which undercut those "secure pinnings" promised in the personalized medicine program promoted by Msrs. Gabriel. This seeming affiliation w/ PharmEco thru a subsidiary was viewed by investors a strong connection he brought to the Board. My subsequent view was equally influenced to the negative after it was revealed that although the pipeline products in their portfolio had viablility, the finacials were unsustainable. It would appear to me, even at this late date, that the money aspect would have been one of the first elements to consider in acquisitioning. It was during this time and for this purpose that I personally felt the LJG Commitment was made. As a shareholder, I feel duped in this regards and would hope that someone who attends the shareholder meeting addresses this aspect. Perhaps I my confused conclusions in this can be cleared up. I hope so, for if memory serves me, we had a substainable .05 pps level prior to this and it was the push for recognition w/ WSG, etc. that added to the upscale of debt ratio that is weighing DnaPrint down. From my limited viewpoint, we already had the necessary exposure in Forensics to bring in that present cash flow and Ancestery being promoted in their different areas could have been established w/out great expenditure. Like I have said, I am not a "bean counter" but our increased exposure hasn't done much for the bottom line.
Here it is at it's basic level for me. Whenever Dr. Frudakis speaks about technical advancements, I am opptomistically invigorated in my view of the potential value of my investment.
He is abreast in the R&D view, but I don't see where Richard has brought about the realization. Ok, I am impatient, but I can't see handing Richard a blank check based on his current history here.
Easy
Peace, Blessings & Boat Drinks, Easy
Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024 • ACGX • Aug 14, 2024 8:30 AM
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions • AVAI • Aug 14, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM